Log In
BCIQ
Print this Print this
 

PROMETHEUS IBD Serology 7

  Manage Alerts
Collapse Summary General Information
Company Nestle S.A.
DescriptionInflammatory bowel disease test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationAutoimmune, Diagnostic
Indication DetailsDiagnose inflammatory bowel disease and differentiate between ulcerative colitis and Crohn's disease (CD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/14/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today